Advisor Group Holdings, Inc. Scynexis Inc Transaction History
Advisor Group Holdings, Inc.
- $67.1 Billion
- Q3 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Scynexis Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,730 shares of SCYX stock, worth $1,020. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,730
Previous 1,730
-0.0%
Holding current value
$1,020
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SCYX
# of Institutions
47Shares Held
12.5MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX3.35MShares$1.98 Million1.43% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.32 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.04 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.58MShares$934,1750.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$327,7770.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $19.3M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...